Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. - Wikidata - wikimedia - TriplyDB

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

http://www.wikidata.org/entity/Q37723417

about

Recent imaging advances in neurology.Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer's disease.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.Decreased Regional Cerebral Perfusion in Moderate-Severe Obstructive Sleep Apnoea during Wakefulness.The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers.A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment.Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.Molecular and cellular pathophysiology of preclinical Alzheimer's disease.Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Astrocyte dysfunction in Alzheimer disease.Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis.Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume.Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.The vascular basement membrane in the healthy and pathological brain.Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment.Changes of Cerebral Perfusion and Functional Brain Network Organization in Patients with Mild Cognitive Impairment.Blunted cerebrovascular response is associated with elevated beta-amyloid.Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients.Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.

P2860

Q30916063-FEF54B03-CB35-44A9-82A4-CACB79DE88A4 Q30937478-4074A118-E2E2-4AAA-80E3-2275D30394FF Q30981669-8FD821A0-6DCF-48B2-ACDF-600B2C1B7CF5 Q31048037-6F8C433A-59F2-4D2D-AA5A-575893CA3D03 Q33775095-BA2D830C-84A0-4FC0-8CC4-D841956DEB81 Q33822159-5164580A-BF5B-4A78-840C-9AE44B8B3B40 Q35119389-96B5B805-A177-4CCA-AD34-54F9B799CDB6 Q35232491-AF345902-B03B-4950-8481-5FEBA3851A51 Q35478501-2F4F6BED-6087-4C0F-9534-5627991836E1 Q36254382-D6E1F6AE-D3E6-40C9-A958-25BE23AD458F Q36692478-FA47CFB2-1A3A-453C-9313-0D4859250C9E Q36767039-239FACBF-6CCA-4490-837A-D4224FA693D5 Q36933698-6BC4B2DD-8D80-4526-83DC-B6590D4E5E40 Q37639685-C4238E40-453D-40AB-B4AB-33F974ADE480 Q38836004-047CD51F-7552-472B-92DD-5E66AD4564C1 Q38879090-80AC0BFA-0234-4521-ACFA-672ED4AE5A7C Q38979999-EDC89E03-3F8F-47FD-8343-92B35B2C8DC3 Q39280590-7C530C25-275F-4F68-8D70-C4571781F3AE Q39547833-F6E214E8-681C-4BD6-BE2F-D4C11F6A673F Q41151211-55510B30-2A6D-4016-9307-B2DC82895F60 Q41907734-A9BEE6F0-0B42-4A1C-9BED-2E0271B3BC9B Q42653687-22D60C12-12A5-4BCC-BEE2-8149F52CC40B Q46398713-67966C80-B19D-4CB0-B6E5-502350BF8E61 Q47095000-B49880C7-2FFA-47BE-9157-EB6E2AE9F288 Q48017362-6FC6CC9F-1E99-4DAF-8FB9-D50CA69BE96A Q48182589-822DE607-1CBE-4FCC-B55B-C2F40AB86E20 Q48547590-A50186B6-9D07-4522-A904-A440BB55690B Q50073607-77B4B568-C925-4A48-8E77-B243AFB9342C Q50534861-11B3A86D-D879-48A4-9AA9-2A4619E0233F Q53396334-5F7E84FD-EEEC-4C13-97D6-1FDC2BC130D2

P2860

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

http://www.wikidata.org/entity/Q37723417

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Association of brain amyloid-β ...... and mild cognitive impairment.

@en

Association of brain amyloid-β ...... and mild cognitive impairment.

@nl

type

label

Association of brain amyloid-β ...... and mild cognitive impairment.

@en

Association of brain amyloid-β ...... and mild cognitive impairment.

@nl

prefLabel

Association of brain amyloid-β ...... and mild cognitive impairment.

@en

Association of brain amyloid-β ...... and mild cognitive impairment.

@nl

P1433

Q37723417-15B6A25E-492F-4B11-B720-E7D24D31BC2C

P1476

Q37723417-30E98F4A-5DBA-454A-B6F0-164236186DBB

P2093

Q37723417-2E37AABF-4152-4715-BDBB-1067BBF1865A

Q37723417-5F9F7DC7-4995-4A26-8F32-4EF0E1B000E9

Q37723417-AE0674B8-B6A5-4338-89F3-3B561A1E383D

Q37723417-BE08115A-5A40-4829-A20D-0586BDB2AE3A

Q37723417-C96D744D-0654-42A7-8013-BE7834530E02

Q37723417-E89295BF-030C-4189-9F87-956DC87A52EA

P2860

Q37723417-0145F9BC-FB17-4DFE-97FC-470740FA732D

Q37723417-058361E7-47BC-4DC7-93C6-7BBD32E191A7

Q37723417-08A42BB2-9A0D-44B5-9561-BBFA6E85A6C5

Q37723417-23BCBDB0-4E3B-46AD-B326-EE9B70A50308

Q37723417-2957A2EA-4B61-4E8B-B0A1-671FC786E274

Q37723417-2B9FC814-C7B8-48B0-927F-93AA74E13022

Q37723417-31B4B7F5-4C00-459F-B2D8-A52598A8CF2D

Q37723417-3B84593D-1C27-4337-B909-0F498A29A27C

Q37723417-3D308931-0FBD-49D1-A906-EC526EF0CEE5

Q37723417-3E03F949-AA1C-4BB6-82C7-DE8B9F6C3CAA

P304

Q37723417-DE18A763-4980-4005-ABB1-1783C0BE8311

P31

Q37723417-356CB4DD-2C6C-4B28-9A38-3C2F9ED41664

P356

Q37723417-5B7DB421-463D-474F-A427-B3CD48156C13

P407

Q37723417-12E72405-16B5-4BEB-9AED-D21284714D67

P433

Q37723417-12FEAA9B-302C-40E3-9F3E-5FCAAF3ACBD2

P478

Q37723417-63092702-CB89-4D12-8B30-B6271F37876D

P50

Q37723417-084F17E9-243B-4DE8-AFE5-447DE27F8B9A

Q37723417-1747053B-55B5-43C7-B746-23877A740A78

Q37723417-44018B8A-904F-4202-9D0D-59B3170BE429

Q37723417-9B01B01B-4886-4081-AA56-607D754701EF

Q37723417-FFD99557-F17C-4D4F-893A-E1463F5814F6

P577

Q37723417-355D9E73-29B6-4034-ACC3-3820EB6A4A2C

P5875

Q37723417-0EECA1EE-5C00-47A1-9668-ADE1AA524EA7

P698

Q37723417-76CA00F6-8A94-4FFD-8537-34C913DA1919

P921

Q37723417-FFCA7A2E-1450-48A0-ABA7-F729E8DB5388

P932

Q37723417-20F4878C-A3BC-4535-A968-D08E10E26427

P356

P1433

P1476

Association of brain amyloid-β ...... and mild cognitive impairment.

@en

P2093

Alix Simonson

http://www.w3.org/2001/XMLSchema#string

Duygu Tosun

http://www.w3.org/2001/XMLSchema#string

Laurel A Beckett

http://www.w3.org/2001/XMLSchema#string

Michael Donohue

http://www.w3.org/2001/XMLSchema#string

Norbert Schuff

http://www.w3.org/2001/XMLSchema#string

Philip S Insel

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

Alzheimer's disease

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

Perfusion imaging.

P304

1550-1561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWU043

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 5

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

Michael W. Weiner

William J. Jagust

Niklas Mattsson

P577

2014-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262047039

http://www.w3.org/2001/XMLSchema#string

P698

24625697

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3999717

http://www.w3.org/2001/XMLSchema#string